Albumin in Acute Stroke "ALIAS - Pilot"

Completed

Phase N/A Results

Summary of Purpose

To determine the safety and efficacy of administering moderate-dose human serum albumin intravenously to ischemic stroke patients.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 25 June 2010.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • NIH Grant NS 40406

Trial Design

Multi-center, non-randomized, multiple-tier, dose-escalation, pilot study with 2 cohorts and 6 tiers.

Contacts

Not available